$HESM

Hess Midstream (HESM) Q2 2026 Earnings Call Transcript

Hess Midstream LP (HESM) reported Q2 2026 net income of $173.7 million, down from $179.7 million a year earlier, with adjusted EBITDA of $313.7 million and total revenues of $399.0 million. The company set Q3 2026 guidance for net income of $165 million to $175 million and reaffirmed 2026 guidance, including net income $650 million to $700 million.

Original reporting
Published Aug 11, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hess Midstream (HESM) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$HESMNeutralMed
01

Why it matters

Traders can update models for 2026 net income, adjusted EBITDA, and adjusted free cash flow, and reassess Q3 expectations given throughput declines and planned maintenance at Little Missouri 4.

02

Market read

The call provides actionable forward ranges for earnings and cash flow plus operational throughput detail that can drive near-term positioning around distribution growth and execution risk.

03

What to watch

Execution risk remains tied to weather and maintenance cost overruns, and multiple throughput metrics (crude terminaling, water gathering, gas processing) are down year over year.

Relevance 8/10Novelty 6/10Timing: pre-market/at the time of the Q2 2026 earnings call and release

Background

The piece is a transcript of Hess Midstream LP’s Q2 2026 earnings call, covering operating results, guidance, and key operational drivers (Tioga maintenance, Bakken laterals, and Chevron integration synergies).

Company-level read

Ticker impact

$HESMNeutralMedium confidence
Context

Hess Midstream reported Q2 2026 results and reaffirmed 2026 guidance, including net income $650M-$700M and adjusted EBITDA $1.225B-$1.275B.

Expected impact

Moderate near-term volatility risk around Q3 volume and cost execution versus the reaffirmed ranges.

Evidence & confidence

The article provides concrete quarterly metrics and forward guidance ranges, but it is a transcript-style disclosure without an explicit surprise versus prior expectations.

Market effects

Reinforces midstream earnings sensitivity to maintenance phasing, throughput volumes, and operating leverage in shale basins.

Highlights Bakken/Tioga and North Dakota processing and terminaling throughput trends that can influence local service demand.

Limited direct global linkage; primarily impacts US natural gas and crude midstream sentiment.

Counterpoint

The 85% gross adjusted EBITDA margin may be flattered by credits and expense phasing, so normalized margins could be lower than the headline suggests.

Key entities

  • Hess Midstream LP

    Midstream operator reporting Q2 2026 results and reaffirming 2026 guidance, including distribution growth and leverage targets.

  • Chevron

    Referenced as optimizing Bakken operations with longer laterals, supporting midstream capital efficiency and throughput.

Related articles

$HESMMed

Why is Hess Midstream Partners stock rallying today?

Hess Midstream Partners shares rose 2.6% pre-open after the company reported Q2 2026 results. Adjusted EPS per unit was $0.75 vs $0.69 consensus, and revenue was $399M vs $396.46M. The firm reaffirmed full-year guidance and declared a quarterly cash distribution of about $0.789 per Class A share, with ex-dividend Aug. 6.

$HESMMed

Hess Midstream (HESM) Cut to Underweight by Morgan Stanley on Risk-Reward Concerns

Morgan Stanley downgraded Hess Midstream LP (HESM) to Underweight from Equal Weight on June 10, citing limited visibility into long-term growth and sponsor strategy, and an unfavorable risk/reward. It set a $38 price target. In its Q1 2026 call, CEO Jonathan Stein said the firm completed a $60 million share/unit repurchase in March and increased Class A distributions by 2% (about 8% annualized).

$HALOHighAI 9/10

Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know

Halozyme Therapeutics (NASDAQ:HALO) shares rose about 18% after the company reported Q2 adjusted EPS of $2.28 on revenue of $481 million, beating consensus of $1.82 and $404.3 million. Halozyme cited 47.7% YoY revenue growth from ENHANZE royalties and milestones. It raised full-year guidance to $1.87B revenue and $8.83 adjusted EPS midpoint.

$FIVNHighAI 9/10

Five9 (FIVN) Stock Trades Up, Here Is Why

Five9 (NASDAQ:FIVN) shares rose about 18% after the company reported Q2 results above Wall Street expectations. Adjusted EPS was $0.70 on revenue of $312.4 million, with revenue up 10.3% year over year. Five9 raised full-year revenue guidance to $1.27 billion at the midpoint and forecast next-quarter sales above consensus.

$SMCIHigh

Super Micro Already Told Us Its Revenue, Its Margins, and Its Orders. Tuesday's Report Has One Number Left.

Super Micro Computer (SMCI) preannounced fiscal Q4 results for the period ended June 30, saying revenue would be near the low end of $11.0B to $12.5B, gross margin 15% to 17%, and new orders over $60B, lifting backlog to record levels. The full results on Tuesday are expected to include a fiscal 2027 outlook. Shares trade in the low $30s, down about 45% from the 52-week high.